Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$229.22M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 4.47%
Avg Daily Range (30 D):	$0.30 | 4.75%
Avg Daily Range (90 D):	$0.33 | 4.25%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	2.14M
Avg Daily Volume (90 D):	1.29M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	172
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	885
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.09M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.51M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$1.1M
Avg Closing Volume:	171.61K

News

Jun 2, 2026 @ 4:56 PM Fulcrum Therapeutics, Inc. Shareholders Are Encour... Source: Johnson Fistel, Pllp

Jun 2, 2026 @ 5:50 AM FULC Stock Crashes After Hours: What Investors Nee... Source: Tanya Rawat

Apr 27, 2026 @ 11:00 AM Fulcrum Therapeutics Announces Recent Business Hig... Source: Not Specified

Mar 19, 2026 @ 12:00 PM MedicAlert Foundation, Sickle Cell Disease Associa... Source: Na

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Financials
	TTM	Q1 2026	Q2 2025
Basic EPS		$-.25	$-.28
Diluted EPS		$-.25	$-.28
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-18.89M	$-17.3M
Operating Income / Loss		$-22.19M	$-19.82M
Cost of Revenue
Net Cash Flow		$-147.27M	$-15.62M
PE Ratio